RT @hkakeya: This is the 2nd time bioRxiv rejects our preprint. In the 1st case, the rejected paper was peer-reviewed and accepted to a jou…

Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies https://t.co/8KT5T4ciXD

This is the 2nd time bioRxiv rejects our preprint. In the 1st case, the rejected paper was peer-reviewed and accepted to a journal shown below. We plan to submit the above preprint to a journal under no pressure from Western virologists to see the result. https://t.co/dLa8IYD6ek

@jpogue1 This isn't the only study. And the Azithromycin would be useful for combating the bacterial pneumonia that's a common complication of covid-19 viral pneumonia. Here's just one other paper. https://t.co/tLTcGYMBgy